Two mouthwashes for gum disease: CHX 0.2% versus CHX 0.12% + CPC
Official title: Comparative Clinical Efficacy and Microbiological Effects of Two Oral Antiseptics Used as an Adjuvant in the Treatment of Severe Periodontitis
Run by The University of Hong Kong · NCT06967402 · Data updated 2026-11-12
This study tests whether a lower-concentration chlorhexidine mouthwash with CPC works as well as a standard chlorhexidine mouthwash as an extra treatment for periodontitis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | November 20, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 23, 2026 |
| Trial ID | NCT06967402 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with generalized stage II–III periodontitis, at least 6 evaluable teeth per quadrant, and no recent antibiotics or CHX/CPC exposure.
✕Probably not a fit
Patients with more advanced disease, significant comorbidities, or non-compliance may not benefit or could be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with generalized stage II–III periodontitis will use a mouthwash as an adjunct to initial periodontal therapy. The study compares CHX 0.2% (control) to CHX 0.12% plus CPC 0.05% (experimental) over about 2 months, assessing inflammation, plaque, and microbiology, as well as patient-reported outcomes. Primary outcome is changes in full mouth bleeding on probing at 2 months after 21 days of daily use. Secondary outcomes include gingival indices, plaque indices, pocket depth, clinical attachment level, microbiological changes, tongue coating and staining, taste irritation, and safety signals.
Why it matters
Potential benefit: If non-inferiority is demonstrated, the lower-concentration mouthwash could reduce side effects while maintaining effectiveness.
How similar studies have gone: Previous antiseptic mouthwashes have shown plaque and inflammation reduction; this study tests a novel combination at lower CHX concentration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Consenting patients with at least 6 evaluable teeth in each quadrant, including minimum 1 molar and 1 premolar. * Generalized stage II-III periodontitis patients. * Baseline BOP \> 25%. * No known allergy or adverse effects to CHX or CPC * Non-smokers, non-orthodontic patients, no concurrent or past antibiotics/medication known to affect periodontal status (i.e. calcium antagonists, phenytoin)/anti-inflammatory therapy (i.e. NASIDs) in the last 3 months, pregnant/breastfeeding, compliance to study procedures. * ASA class I-II patients. * Either non-diabetic or with controlled diabetes (HbA1C\<7). * Normal/Elevated blood pressure (AHA - Systolic \<130mmHg; Diastolic \<80mmHg). * No radiation/chemotherapy in the past 5 years * No immunosuppression including drug induced immunosuppression. * No participation in other clinical studies in the last 4 weeks. * No administration of CHX or CPC in the last 3 months * No periodontal treatment in the last 3 months. Exclusion Criteria: * Unable to provide written consent. * Non-compliant study procedures. * Patients with medical (including psychiatric) and pharmacotherapeutic histories that, in the investigator's opinion, may compromise the protocol. * Patients requiring antibiotics prophylaxis for dental procedures. * Patients with self-reported pregnancy or patients who are breastfeeding. * Patients with history of use of systemic antibiotics, in combination with any form of periodontal treatment, within the past 3 months. * Patients with uncontrolled endocrine disease. * Patients who are not compliant with the review protocol, leading to deviation of more than 1 week. * Patients requiring the admission of systemic antibiotics, in combination with any form of dental treatment, during the study period.
Where it's running
-
HKU Faculty of Dentistry, IAD - Clinical Research Centre
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Melissa Fok, BDS, MDS (Perio), PhD
- Email: melfok@hku.hk
- Phone: +85228590495
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SP-D in GCF: Change after MINST in periodontitis
This study tests whether levels of Surfactant Protein D in gum fluid change after a minimally invasive non-surgical periodontal treatment in adults with periodontitis.
-
3-month liquid platelet-rich fibrin treatment used during deep cleaning for stage II–IV periodontitis
This 3-month test will see if flushing diseased gum pockets with your own liquid platelet-rich fibrin after deep cleaning helps healing for people with stage II–IV periodontitis.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Association Between Periodontitis and Dry Eye Disease in Adults
This study tests whether periodontitis and dry eye disease are linked by comparing groups with and without each condition.
-
Periodontal Infection and Inflammatory Markers in Missed Abortion
Researchers will test whether gum infection and inflammation are linked to missed abortion in pregnant women with no major chromosomal problems.
-
Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease
This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.